APS for Biomedical Research for Reproductive Health

The summary for the APS for Biomedical Research for Reproductive Health grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Agency for International Development, which is the U.S. government agency offering this grant.

APS for Biomedical Research for Reproductive Health: The purpose of the APS is to publicize this United States Government's (USG) plan to fund a limited number of awards through USAID/Washington's Office of Population and Reproductive Health (PRH), and Office of HIV/AIDS (OHA), to address a focused set of family planning/reproductive health (FP/RH) issues. The areas of interest for the APS are listed below. Funds may support the research and development (R&D), regulatory approval, and introduction of new contraceptives that fill existing gaps in the FP method mix, and multipurpose prevention technologies (MPTs) that meet various RH needs of women in low resource settings. The innovative and potentially varied nature of these activities and products, which are united by a theme but not necessarily a common technological platform or programmatic focus, may require a diversity of partners with differing areas of expertise. Thus, the intention of the APS is to marshal the greatest amount of technical expertise for promising product leads and initiatives, while remaining flexible enough to support innovation and respond to the most pressing needs of the field.The objective of the APS is to foster the R&D, regulatory approval, and introduction of:1. New contraceptive methods that fill specific gaps in the existing method mix; 2. MPTs that are contraceptive, and: a. Provide protection from HIV, other sexually transmitted infections (STIs), and/or reproductive tract infections (RTIs);b. Are appropriate for occasional or intermittent use; andc. Provide additional health benefits.The specific aims are discussed in more detail in the Program Description.